{
    "clinical_study": {
        "@rank": "52039", 
        "arm_group": [
            {
                "arm_group_label": "\u226565 years old", 
                "description": "20 patients greater than or equal to 65 years of age"
            }, 
            {
                "arm_group_label": "<65 years old", 
                "description": "20 patients less than 65 years of age"
            }
        ], 
        "biospec_descr": {
            "textblock": "Whole blood"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate the association between the Independent\n      Activities of Daily Living (I-ADL) component of the Comprehensive Geriatric Assessment (CGA)\n      and poor tolerance to radiation treatment in older and younger patients with non-ovarian\n      gynecological cancers."
        }, 
        "brief_title": "Radiation Adherence/Toxicity in Patients With Non-Ovarian Gynecological Cancers", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Non-ovarian Gynecological Cancers", 
        "detailed_description": {
            "textblock": "There are little data regarding the impact of functional age on tolerance to radiotherapy\n      for gynecologic cancers. A comprehensive geriatric assessment (CGA) tool which measures\n      functional status (including the Instrumental Activities of Daily Living (I-ADL)), among\n      many other important geriatric related conditions, was developed by Hurria and colleagues.\n      Geriatric assessment variables including functional status predicted for toxicity in older\n      patients receiving chemotherapy and surgery for multiple cancer types., 2 We hypothesize\n      that I-ADL can be used to predict treatment tolerance in patients of all ages receiving\n      pelvic and/or paraaortic region radiation therapy for gynecologic malignancies."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u2265Age 18 years (no upper age limit)\n\n          -  Diagnosis of cervical, vaginal, vulvar, or endometrial cancer with either pelvic\n             radiotherapy or chemoradiotherapy planned as part of standard treatment.\n\n          -  Consented for receipt of External Beam Radiation Therapy (EBRT) at the University of\n             North Carolina Chapel Hill\n\n          -  Ability to read English (required for CGA)\n\n          -  Curative treatment intent as defined by their radiation oncologist\n\n          -  Negative serum pregnancy test in women of childbearing potential\n\n        Exclusion Criteria:\n\n          -  < Age 18 years\n\n          -  Incurable cancer as defined by their radiation oncologist\n\n          -  Planned radiation for palliative intent only\n\n          -  Inability to complete the I-ADL section of the CGA\n\n          -  Prior radiation to areas targeted by radiotherapy within this study\n\n          -  Other active, invasive malignancy requiring active ongoing therapy during their\n             radiotherapy with the exception of:\n\n          -  Localized squamous cell carcinoma of the skin\n\n          -  Basal-cell carcinoma of the skin\n\n          -  Other malignancies requiring locally ablative therapy only"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients age 18 years of age or above with a diagnosis of cervical, vaginal, vulvar, or\n        endometrial cancer with either pelvic radiotherapy or chemoradiotherapy planned as part of\n        standard treatment with curative intent at the Department of Radiation Oncology at UNC\n        Chapel Hill."
            }
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02003430", 
            "org_study_id": "132824", 
            "secondary_id": "LCCC 1321"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "gynecologic malignancy", 
            "non-ovarian gynecological cancer", 
            "cervical cancer", 
            "vaginal cancer", 
            "vulvar cancer", 
            "endometrial cancer"
        ], 
        "lastchanged_date": "December 2, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chapel Hill", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27599"
                }, 
                "name": "UNC Department of Radiation Oncology Clinic"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Functional Assessment and Radiation Adherence/Toxicity in Older and Younger Patients With Non-Ovarian Gynecological Cancers", 
        "other_outcome": [
            {
                "description": "Patient-reported acute grade 3-5 radiation related toxicities will be based on the PRO-CTCAE questionnaire during and 4-8 weeks post radiation therapy and at 6 months.", 
                "measure": "Patient-reported acute grade 3-5 radiation related toxicities", 
                "safety_issue": "No", 
                "time_frame": "During treatment and 4-8 weeks post-treatment"
            }, 
            {
                "description": "Provider-reported grade 3-5 acute radiation related toxicities will be based on the CTCAE (Common Toxicity Criteria for Adverse Effects) v4.03 during and 4-8 weeks post radiation therapy", 
                "measure": "Provider-reported grade 3-5 acute radiation related toxicities", 
                "safety_issue": "No", 
                "time_frame": "During treatment and 4-8 weeks post-treatment"
            }
        ], 
        "overall_official": [
            {
                "affiliation": "Department of Radiation Oncology, University of North Carolina Chapel Hill", 
                "last_name": "Mahesh Varia, MD, ChB", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Department of Radiation Oncology, Unverisity of North Carolina Chapel Hill", 
                "last_name": "Noam VanderWalde, MD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Pre-treatment I-ADL dependency is defined as scoring less than 14 on the I-ADL scale of the CGA.", 
            "measure": "Pre-treatment I-ADL dependency", 
            "safety_issue": "No", 
            "time_frame": "Pre-treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02003430"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Poor adherence to treatment is defined by at least one of the following:\n> 3 day treatment delay secondary to treatment related toxicity during radiation therapy.\nHospitalization secondary to treatment related toxicity during or up to 4-8 weeks post radiation therapy.\nUnplanned dose reductions in either radiation or concurrent chemotherapy secondary to treatment related toxicity during radiation therapy\nUnplanned change in concurrent chemotherapy regimen secondary to treatment related toxicity during radiation therapy.", 
            "measure": "Poor adherence to treatment", 
            "safety_issue": "No", 
            "time_frame": "During or 4-8 weeks post-treatment"
        }, 
        "source": "UNC Lineberger Comprehensive Cancer Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "UNC Lineberger Comprehensive Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}